Trial
NCT04388163
Gentian Violet Treatment for Hidradenitis Suppurativa
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Hidradenitis Suppurativa
Intervention
Gentian Violet
Why stopped
Drug company did not approve use of the drug, IRB never approved
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-04